Analysis of PROLANIS activities on controlling type-2 diabetes mellitus at Puskesmas Tulungagung in 2022

Kasil Rokhmad, Stefanus Supriyanto

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


Background. Non-communicable diseases are still a global and national problem. Around 71% of deaths worldwide are caused by non-communicable diseases, and about 36 million people per year died from them in 2016. One of these preventions is the prevention of type-2 diabetes mellitus (type-2 DM), which can be done by knowing the risk factors. There are two risk factors for type-2 DM: the ones we can change and the ones we cannot change. We can change our lifestyle, such as what food we con-sume, rest patterns, physical activity, and stress management. In contrast, we cannot change age and genetics. Objective. This research aimed to analyze PROLANIS activities on controlling type-2 diabetes mellitus. Methods. This research is a cross-sectional study carried out at selected Puskesmas (Community Health Center) in Tulungagung Regency between April and July 2022. The selection of research locations was based on the area’s characteristics in Tulungagung Regency, namely urban Puskesmas, rural Puskesmas, and moun-tainous Puskesmas. One Puskesmas represented each region. Results. Based on data from the Health Department of Tulungagung, with the results of 546 type-2 DM patients, only 34% participated in the PROLANIS (chronic disease management program) activities. Of those who participated in PROLANIS, 36% could control their type-2 DM, which means there were still many type-2 DMs that had not been controlled. Conclusion. There was a relationship between attendance in PROLANIS activities and controlled blood sugar levels in patients with type-2 DM.

Original languageEnglish
Article number2617
JournalJournal of Public Health in Africa
Issue numberS2
Publication statusPublished - 25 May 2023


  • blood sugar levels
  • chronic disease management program
  • controlled type-2 DM


Dive into the research topics of 'Analysis of PROLANIS activities on controlling type-2 diabetes mellitus at Puskesmas Tulungagung in 2022'. Together they form a unique fingerprint.

Cite this